Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ALNYLAM PHARMA RG (NQ: ALNY)
97.48 USD  +1.29 (+1.34%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,285,479
Open 96.40
Bid (Size) 95.40 (300)
Ask (Size) 98.55 (100)
Prev. Close 96.19
Today's Range 95.24 - 99.16
52wk Range 49.19 - 153.99
Shares Outstanding 100,171,389
Dividend Yield N/A
Performance
YTD
-26.07%
-26.07%
1 Month
-31.59%
-31.59%
3 Month
-25.59%
-25.59%
6 Month
-15.65%
-15.65%
1 Year
+96.89%
+96.89%
Top News
More News
Trump attacks OPEC, markets plummet
President Donald Trump accused OPEC of artificially inflating crude oil prices. The markets close sharply lower with the Dow plummeting 201 points to 24,462. Nasdaq plunged 91 points to 7146. Read More
category Market News
from MarketMinute.com Market Updates
Dicerna Pharmaceuticals and Alnylam Pharmaceuticals settle suits
Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) and Alynylam Pharmaceuticals Inc. (Nasdaq: ALNY) settled a stolen trade secrets case. Shares of Dicerna Pharmaceuticals soared $1.82 to close at $12.01 while... Read More
from MarketMinute.com Stock News
More News
Read More
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade Secret Misappropriation and Other Pending Litigation
from Business Wire News Releases
Technical Perspectives on Biotech Stocks -- Alnylam Pharma, Amgen, Amicus Therapeutics, and Ampio Pharma
from PR Newswire
Alnylam Presents New Positive Clinical Results for Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias
from Business Wire News Releases
Alnylam Pharmaceuticals Shows Rising Price Performance With Jump To 82 RS Rating
from Investor's Business Daily
UPDATE 2-U.S. biotech companies Alnylam, Dicerna settle trade secrets case
category companyNews
from Reuters: Company News
CORRECTED-UPDATE 1-U.S. biotech companies Alnylam, Dicerna settle trade secrets case
category companyNews
from Reuters: Company News
CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case
category companyNews
from Reuters: Company News
BRIEF-Alnylam Reaches Settlement Agreement With Dicerna Pharmaceuticals
category companyNews
from Reuters: Company News
Why Dicerna Rocketed Higher Today
category ALNY , SNY , DRNA
from Motley Fool
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial